Understanding the risks and benefits of using molecular epidemiology to prevent HIV
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
This study is looking at how understanding the genetic connections of HIV can help improve prevention efforts, and it involves people living with HIV and those at risk to hear their thoughts on the benefits and concerns of this approach.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10834207 on NIH RePORTER |
What this research studies
This research investigates how molecular epidemiology can be used to enhance HIV prevention efforts by examining the ethical, legal, and social implications associated with this approach. It engages individuals living with HIV and those at risk to gather diverse perspectives on the potential benefits and risks of identifying genetically linked HIV sequences. By utilizing real-world data and advanced analytical methods, the study aims to address barriers to implementing effective HIV prevention strategies. The findings will help inform policy development and improve the overall response to HIV prevention.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals living with HIV and those at risk of HIV infection.
Not a fit: Patients who are not at risk for HIV or do not have HIV may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and ethically sound strategies for preventing HIV transmission.
How similar studies have performed: Previous research has shown promise in using molecular epidemiology for infectious disease prevention, indicating potential for success in this area.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Little, Susan Janet — University of California, San Diego
- Study coordinator: Little, Susan Janet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.